CSCO
56
-2
LB
33
11
EFX
50
-2
MOS
29
3
ITW
39
2
XOM
48
-17
AMG
71
-3
MAT
46
-3
MUR
38
5
BK
66
-2
LEN
36
-5
ETN
55
-6
PG
50
-21
AMAT
46
-4
RIG
37
-9
AES
49
-2
VRTX
49
-16
O
39
4
BSX
57
2
V
50
-26
CSCO
56
-2
LB
33
11
EFX
50
-2
MOS
29
3
ITW
39
2
XOM
48
-17
AMG
71
-3
MAT
46
-3
MUR
38
5
BK
66
-2
LEN
36
-5
ETN
55
-6
PG
50
-21
AMAT
46
-4
RIG
37
-9
AES
49
-2
VRTX
49
-16
O
39
4
BSX
57
2
V
50
-26
Financhill
Back

Catalyst Pharmaceuticals, Inc. Stock Predictions

Share Price Moved. Momentum Hasn't Slowed.

DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Buy
80

CPRX
Catalyst Pharmaceuticals, Inc.

Last Price:
$23.69
Seasonality Move:
6.75%

7 Day Trial

ALL ACCESS PASS

$ 7

14K Investors Got In Earlier. You Still Can.

DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi

Catalyst Pharmaceuticals, Inc. Stock Forecast

  • Over the next 52 weeks, Catalyst Pharmaceuticals, Inc. has on average historically risen by 38.3% based on the past 19 years of stock performance.
  • Catalyst Pharmaceuticals, Inc. has risen higher in 10 of those 19 years over the subsequent 52-week period, corresponding to a historical accuracy of 52.63%
  • Is Catalyst Pharmaceuticals, Inc. Stock Undervalued?
    The current Catalyst Pharmaceuticals, Inc. [CPRX] share price is $24.00. The Score for CPRX is 80, which is 60% above its historic median score of 50, and infers lower risk than normal.
  • CPRX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.

Will Catalyst Pharmaceuticals, Inc. Stock Go Up Next Year?

  • Over the next 52 weeks, Catalyst Pharmaceuticals, Inc. has on average historically risen by 38.3% based on the past 19 years of stock performance.

Catalyst Pharmaceuticals, Inc. Stock Rating

Buy
80
Catalyst Pharmaceuticals, Inc. (CPRX) is a Buy

Is Catalyst Pharmaceuticals, Inc. overpriced?

  • Catalyst Pharmaceuticals, Inc. has risen higher in 10 of those 19 years over the subsequent 52-week period, corresponding to a historical accuracy of 52.63%

Catalyst Pharmaceuticals, Inc. Stock Price History

Is CPRX stock going to rise?

  • The current trend is moderately bullish and CPRX is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
catalystpharma.com

52-Week Data

52-Week High:
26.58
52-Week Low:
19.05

Prediction Charts

Market Cap:
2.9B
Price in USD:
24.00
Volume:
1.4M
Beta:
1.05

Technical Analysis

SMA50:
22.12
SMA100:
21.23
SMA200:
22.13
52-Wk Change:
8.74%

Stock Predictions

  • Is Catalyst Pharmaceuticals, Inc. stock public?
    Yes, Catalyst Pharmaceuticals, Inc. is a publicly traded company.
  • What is the Catalyst Pharmaceuticals, Inc. stock quote today?
    The Catalyst Pharmaceuticals, Inc. stock price is 24.00 USD today.
  • How to buy Catalyst Pharmaceuticals, Inc. stock online?
    You can buy Catalyst Pharmaceuticals, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Nov-28 23.39 23.41 23.45 23.20
Dec-1 23.14 22.69 23.15 22.64
Dec-2 22.79 22.62 22.93 22.42
Dec-3 22.82 23.10 23.24 22.66
Dec-4 22.85 23.08 23.22 22.56
Dec-5 23.08 23.53 23.55 23.02
Dec-8 23.74 23.16 23.84 23.12
Dec-9 23.21 22.55 23.31 22.50
Dec-10 22.50 22.80 22.86 22.20
Dec-11 22.88 22.94 23.39 22.80
Dec-12 23.06 23.62 23.84 22.67
Dec-15 23.69 24.18 25.14 23.69
Dec-16 24.18 24.19 24.50 24.01
Dec-17 24.07 24.00 24.45 23.88

Catalyst Pharmaceuticals, Inc. Earnings

Catalyst Pharmaceuticals, Inc. Earnings Report: Per Share Catalyst Pharmaceuticals, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.

Catalyst Pharmaceuticals, Inc. Forecast Revenue Growth

Catalyst Pharmaceuticals, Inc. Stock Analysis: Historical quarterly revenues per share for Catalyst Pharmaceuticals, Inc. and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.45 per share, and an increase next year of $0.08 per share.

* Catalyst Pharmaceuticals, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.